The Company is investigating novel molecules within the CYB005 program at non-hallucinogenic doses for a range of Central Nervous System (“CNS”) disorders. In addition, the Company is continuing to ...
In healthcare, LTTS’ Software Defined Architectures, powered by NVIDIA Holoscan and NVIDIA IGX, are set to transform healthcare delivery with AI-based diagnostics, real-time data analysis, and ...